SureTrader Nadex Advertisement Interactive Brokers Advertisement SureTrader
Home > Boards > US OTC > Medical - Equipment >

Arrayit Corporation (ARYC)

Add ARYC Price Alert      Hide Sticky   Hide Intro
Moderator: techmover, Penny Traders Club, bz777, UndervaluedStocks, HighYieldStocks
Search This Board: 
Last Post: 5/30/2017 3:32:20 AM - Followers: 396 - Board type: Free - Posts Today: 1



Arrayit (ARYC) leads and empowers the genetic, research, pharmaceutical, and diagnostic communities through the discovery, development and manufacture of proprietary life science technologies and consumables for disease prevention, treatment and cure.


- Powerful Science for Life™



Corporate Overview

Arrayit Corporation is a leading life sciences company providing innovative products and services to empower scientists and clinicians to explore the human genome as well as the genomes of plants and animals. Arrayit's worldwide business position leverages the company's widely used patented microarray manufacturing platform and revolutionary VIP™ genotyping technology. Nearly every major research center in the world uses Arrayit products including research laboratories, pharmaceutical companies, universities, biotechnology companies, hospitals, government agencies, and nonprofit research organizations. Novel insights into the function of genes and proteins, early stage disease diagnostics, better and safer medicines, and more nutritional crop plants are some of the many aspects of human health empowered by Arrayit technology.

Corporate Philosophy
Arrayit is an exciting and innovative public company that strives to increase shareholder equity by inventing, developing, manufacturing and supplying sophisticated life sciences products and services to an extensive customer base spanning 50 countries.
Our corporate philosophy is embodied by a highly skilled, multidisciplinary team of investors, business professionals, scientists, engineers and executive and support staff who place shareholder value, product quality, customer service and price competitiveness as our highest priorities. Arrayit empowers decisive strategic advantage and large return on investment for our customers in the research, pharmaceutical, diagnostic, and health care markets.

Corporate History
Arrayit Corporation was founded in 1993 by Rene' Schena and Todd Martinsky as TeleChem International, Inc, a chemical import and export company specializing in plastics, water soluble fertilizers, alternative fuels, and the life sciences. After several years of successful revenues growth, the company expanded in 1999 by adding Dr. Mark Schena and Paul Haje, who together with Ms. Schena and Mr. Martinsky, founded Arrayit Life Sciences, a division of TeleChem International, Inc. Arrayit sought to build on the opportunities created by the deciphering of the human genome and the rise of microarray technology. Arrayit microarrays are sophisticated glass substrates containing large collections of DNA and protein spots that allow all 25,000 human genes and every major protein in the human body to be analyzed in a few hours. Arrayit VIP™ microarrays enable the analysis of the DNA from 100,000 patients in one day. Since 1999, Arrayit has has build a powerful portfolio of patents, trade secrets, and more than 650 life sciences products. The company was featured on the television series
NOVA in 2001, received successive appointments to the Inc. 500 list in 2002 and 2003, and has received numerous local awards including the Rising Star award from the City of Sunnyvale and the Silicon Valley 50 award in 2003. The company changed its name to Arrayit Corporation and began trading on the OTC Bulletin Board in 2009 as ticker symbol ARYC. The company's products and services are used in the life sciences, pharmaceutical, and diagnostics markets, which are estimated at $690 billion in annual revenue.


OvaDx® Ovarian Cancer Diagnostic Test

In Development

Arrayit Diagnostics, Inc. provides the market's first large panel biomarker screening test for ovarian cancer. OvaDx® is a sophisticated microarray-based test that measures the activation of the immune system in blood samples in response to early stage ovarian tumor cell development. Research studies with OvaDx® indicate high sensitivity and specificity for all types and stages of ovarian cancer including stage IA-IV borderline serous, clear cell, endometrioid, mixed epithelial, mucinous, serous, and ovarian adenocarcinoma. Upon FDA approval, Arrayit Diagnostics will offer OvaDx® as an elective test for women seeking greater wellness and for women in the elevated risk category for ovarian cancer. OvaDx® will be used by doctors to advance the forefront of ovarian cancer treatment including improved surgical options, more effective chemotherapies, and to supplement existing tests including CA-125, OVA1®, and transvaginal ultrasound.


Diagnostics - Parkinson's Disease

Parkinsons Disease
Arrayit has leveraged the company's patented and proprietary microarray discovery platform to decipher the molecular basis of Parkinson's Disease (PD). This important research project, completed as a collaboration with The Parkinson's Institute (Sunnyvale, California), offers exciting promise for the pre-symptomatic and post-symptomatic diagnosis and treatment of this serious neurodegenerative condition. Arrayit is currently seeking a strategic partner to accelerate FDA approval of the Arrayit PDx™ Parkinson's Disagnostic Test, speed the benchmarking of PDx™ as a companion diagnostic, and determine and enhance the efficacy of pipeline therapeutic proteins and small molecules.


Avant Diagnostics, Inc.

Definitive diagnostic screening test for early stage detection


About Avant Diagnostics, Inc.


Avant Diagnostics, Inc., ("AD") previously named Arrayit Diagnostics, Inc., is a Nevada corporation presently a majority-owned subsidiary of Arrayit Corporation ("Arrayit"). AD's business is based upon the completion of the human genome sequencing project. Genetic research is increasingly focused on identifying the variations of the specific genes in the genome. These variations are what define individual characteristics, including disease states or a statistical propensity for disease. The implications are far-reaching and impact not only the research community, but also the individual patients and the medical providers. Diagnostic tests that detect diseases very early in their progression will provide options for earlier treatments that may improve the patient's quality of life and prognosis by delaying or preventing disease progression or even death. Medical providers will incur major cost savings by avoiding costly late stage disease treatments.


© 2013 by Avant Diagnostics, Inc., all rights reserved.

Related Articles

  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
Current Price
Bid Ask Day's Range
ARYC News: Current Report Filing (8-k) 12/05/2016 04:31:06 PM
ARYC News: Current Report Filing (8-k) 12/05/2016 03:16:26 PM
#46478  Sticky Note We expect an immediate share price increase upon techmover 05/25/17 05:24:04 PM
#45802  Sticky Note If you are new to the ARYC board, UndervaluedStocks 05/10/17 02:54:43 PM
#45708  Sticky Note NEW...Arrayit to double manufacturing capacity by 6/30/2017 to HighYieldStocks 05/08/17 11:49:19 AM
#42929  Sticky Note ***Ten Reasons To Invest in Arrayit Corporation (ARYC)*** Penny Traders Club 04/01/17 11:54:57 AM
#41045  Sticky Note Here are the details and DD updates StockZoom 02/08/17 10:32:34 AM
#46576   NEW...Arrayit May 28 2017 newsletter features our top HighYieldStocks 05/30/17 03:32:20 AM
#46575   Aryc barchart opinion is buy and the chart Ken1998 05/29/17 10:14:00 PM
#46574   ARYC....JUST.A.REMINDER...GROSS.PROFIT.HARDWARE...53%..TECHNOLOGY...80%...SERVIC tm1119 05/29/17 02:43:44 PM
#46572   "I think I read somewhere" UndervaluedStocks 05/29/17 02:31:59 PM
#46571   The true reality is that Arrayit is bringing UndervaluedStocks 05/29/17 01:50:06 PM
#46569   I think I read in a post that MikeCr 05/29/17 12:09:06 PM
#46568   ARYC.....DAMAGES.CLAIMED.BY.TAUB.....SUIT.1...6MIL...SUIT.2...252MIL.. tm1119 05/29/17 11:44:17 AM
#46567   I think I read somewhere in a post, MikeCr 05/29/17 11:21:20 AM
#46566   If you are new to the ARYC board, UndervaluedStocks 05/28/17 08:59:18 PM
#46565   Arrayit May 28 2017 newsletter features our top HotStockAlerts 05/28/17 07:59:43 PM
#46564   It's frivolous and the company is intentionally delaying UndervaluedStocks 05/28/17 06:43:28 PM
#46563   What are they asking for in damages? If TravO 05/28/17 02:39:04 PM
#46562   I'm not up to speed as to all MikeCr 05/28/17 01:24:00 PM
#46561   ARYC....OK...QUESTION? WHEN WAS THIS COURT STATEMENT MADE? tm1119 05/28/17 12:40:16 PM
#46560   I don't know all the claims that still MikeCr 05/28/17 11:29:50 AM
#46559 StockHobit 05/28/17 12:35:22 AM
#46558   Arrayit quotes $190,000 microarray technology platform to world UndervaluedStocks 05/27/17 11:33:36 PM
#46557   Arrayit reports $18,500 microarray technology sale to top UndervaluedStocks 05/27/17 11:33:15 PM
#46556   Arrayit reports $53,700 microarray services sale to a UndervaluedStocks 05/27/17 11:32:57 PM
#46555   Arrayit reports $40,500 microarray technology sale to a UndervaluedStocks 05/27/17 11:28:57 PM
#46554   Arrayit ships $168,000 microarray platform to healthcare leader UndervaluedStocks 05/27/17 11:28:23 PM
#46553   Arrayit reports $29,200 microarray services sale to a UndervaluedStocks 05/27/17 11:27:52 PM
#46552   Arrayit reports $27,000 microarray services sale to a UndervaluedStocks 05/27/17 11:27:35 PM
#46551   Arrayit reports $29,800 microarray services sale to a UndervaluedStocks 05/27/17 11:26:23 PM
#46550   Arrayit reports $25,900 microarray services sale to a UndervaluedStocks 05/27/17 11:26:00 PM
#46549   Arrayit reports $15,000 microarray technology sale to antibody UndervaluedStocks 05/27/17 11:25:30 PM
#46548   Arrayit reports $34K microarray instrument sale to top UndervaluedStocks 05/27/17 11:24:42 PM
#46547   Arrayit reports $100K microarray technology sale to world UndervaluedStocks 05/27/17 11:24:14 PM
#46545   Agreed! HotStockAlerts 05/27/17 02:31:17 PM
#46544   Overall it looks like good news to ARYC Ken1998 05/27/17 02:30:15 PM
#46543   "Then after that I suppose they will go UndervaluedStocks 05/27/17 02:26:10 PM
#46542   ARYC....MikeCr....WHAT.CLAIMS.ARE.LEFT...?? tm1119 05/27/17 02:24:50 PM
#46541   The judge had dismissed some of the claims MikeCr 05/27/17 02:14:03 PM
#46540   ARYC....T.H.A.N.K.S..A.G.A.I.N.....Ken1998....YOU'RE.RIGHT.ON.THE.MONEY....OUR. tm1119 05/27/17 01:59:21 PM
#46539   Ok thanks. Mike, Ken and tm... Buckstopshere 05/27/17 01:55:37 PM
#46538   Taub must have filed for reconsideration due to MikeDyr 05/27/17 01:54:14 PM
#46537   Based on previous update, the judge thought Ken1998 05/27/17 01:52:30 PM
#46536   "Opposition" to reconsideration MikeDyr 05/27/17 01:47:42 PM
#46535   ARYC....KINDLY...REPOST.PACER.INFO....I'LL.EXPLAIN.IT.... tm1119 05/27/17 01:44:33 PM
#46534   How do you see it as great news? Buckstopshere 05/27/17 01:38:22 PM
#46533   That would mean that arrayit does not agree Buckstopshere 05/27/17 12:56:45 PM
#46532   Then why would arrayit file motion for reconsideration Buckstopshere 05/27/17 12:55:42 PM
#46531   Sounds like it! Alyssa 05/27/17 12:46:34 PM
#46530   So there must have been a dismissal on Buckstopshere 05/27/17 11:31:04 AM
#46529   ARYC share price will be a lot higher UndervaluedStocks 05/27/17 11:21:46 AM
#46528   Well we're talking a few years to reach techmover 05/27/17 11:13:38 AM
#46527   ARYC itself thinks they can get to 0.085 MikeCr 05/27/17 11:06:33 AM
#46526   When ARYC share price is .75+ next year, UndervaluedStocks 05/27/17 10:57:45 AM
#46525   To list on NASDAQ they need to have MikeCr 05/27/17 10:55:19 AM
#46524   ARYC....Ken1998....T.H.A.N.K..Y.O.U....GREAT..NEWS..!!..GLTA tm1119 05/27/17 10:50:21 AM